Cited by 134Metabolism and Genetic DisordersDrug Transport and Resistance MechanismsCholesterol and Lipid Metabolism

A novel bile acid biosynthesis defect due to a deficiency of peroxisomal ABCD3

Open access
Ferdinandusse, Sacha, Jimenez-Sanchez, Gerardo, Koster, Janet, Denis, Simone, Van Roermund, Carlo W., Silva-Zolezzi, Irma, Moser, Ann B., Visser, Wouter F. +7 more·2015·Human Molecular Genetics

Abstract

ABCD3 is one of three ATP-binding cassette (ABC) transporters present in the peroxisomal membrane catalyzing ATP-dependent transport of substrates for metabolic pathways localized in peroxisomes. So far, the precise function of ABCD3 is not known. Here, we report the identification of the first patient with a defect of ABCD3. The patient presented with hepatosplenomegaly and severe liver disease and showed a striking accumulation of peroxisomal C27-bile acid intermediates in plasma. Investigation of peroxisomal parameters in skin fibroblasts revealed a reduced number of enlarged import-competent peroxisomes. Peroxisomal beta-oxidation of C26:0 was normal, but beta-oxidation of pristanic acid was reduced. Genetic analysis revealed a homozygous deletion at the DNA level of 1758bp, predicted to result in a truncated ABCD3 protein lacking the C-terminal 24 amino acids (p.Y635NfsX1). Liver disease progressed and the patient required liver transplantation at 4 years of age but expired shortly after transplantation. To corroborate our findings in the patient, we studied a previously generated Abcd3 knockout mouse model. Abcd3-/- mice accumulated the branched chain fatty acid phytanic acid after phytol loading. In addition, analysis of bile acids revealed a reduction of C24 bile acids, whereas C27-bile acid intermediates were significantly increased in liver, bile and intestine of Abcd3-/- mice. Thus, both in the patient and in Abcd3-/- mice, there was evidence of a bile acid biosynthesis defect. In conclusion, our studies show that ABCD3 is involved in transport of branched-chain fatty acids and C27 bile acids into the peroxisome and that this is a crucial step in bile acid biosynthesis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddu448

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Different substrate preferences were suggested for ABCD1-3: straight-chain VLCFAs for ABCD1, unsaturated VLCFAs for ABCD2, and branched-chain fatty acids, dicarboxylic acids, and bile acid precursors for ABCD3.

    “Different substrate preferences were suggested for ABCD1-3: straight-chain VLCFAs for ABCD1, unsaturated VLCFAs for ABCD2, and branched-chain fatty acids, dicarboxylic acids, and bile acid precursors for ABCD3.122–124”

    From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [124]

    The supplied passages contain no match for the claim. Searches of our copy for ABCD1, ABCD2, ABCD3, dicarboxylic acids, and substrate specificity returned no passages, so I cannot verify the proposed substrate preferences from this source. (LLM, conf=0.65)

    Experimental — accuracy not yet measured
  • A further explanation for the lack of compensation in vivo may be different affinities toward VLCFAs.

    “A further explanation for the lack of compensation in vivo may be different affinities toward VLCFAs.”

    From The genetic landscape of X-linked adrenoleukodystrophy: inheritance, mutations, modifier genes, and diagnosis (2015) · cites this paper as [124]

    No passage from our indexed copy addresses whether different affinities for very-long-chain fatty acids could explain a lack of compensation in vivo. Searches for the claim’s wording, VLCFA, affinity, and compensation found no relevant passage. (LLM, conf=0.70)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Ferdinandusse, S., Jimenez-Sanchez, G., Koster, J., Denis, S., Van Roermund, C. W., Silva-Zolezzi, I., Moser, A. B., Visser, W. F., Gulluoglu, M., Durmaz, O., Demirkol, M., Waterham, H. R., Gökcay, G., Wanders, R. J. A., & Valle, D.
Affiliations
  • Amsterdam UMC Location University of Amsterdam (NL)
  • Kennedy Krieger Institute (US)
  • Johns Hopkins University (US)
Corresponding author
Ferdinandusse, Sacha
Venue
Human Molecular Genetics
Published
2014-08-28
Volume
24
Issue
2
Pages
361-370
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2152977496
Cited by
134
References
8
Citations by year
2026: 6 · 2025: 11 · 2024: 10 · 2023: 9 · 2022: 17 · 2021: 9 · 2020: 11 · 2019: 16 · 2018: 16 · 2017: 9 · 2016: 8 · 2015: 11
FWCI
6.41
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion, other-oa)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Metabolism and Genetic Disorders
  • Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
  • Health Sciences › Medicine › Surgery › Cholesterol and Lipid Metabolism
Keywords
ABCD3, peroxisomal ABC transporters, bile acid synthesis, phytanic acid, peroxisomal import, hepatosplenomegaly, liver disease, peroxisome biogenesis disorders
MeSH terms
Animals, Bile Acids and Salts, Fatty Acids, Female, Humans, Liver Diseases, Male, Mice, Knockout, ATP-Binding Cassette Transporters, Peroxisomes, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review